TFF Pharmaceuticals Investor Relations Material
Latest events
Study Update
TFF Pharmaceuticals
Q3 2024
20 Nov, 2024
Q2 2024
14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TFF Pharmaceuticals Inc
Access all reports
TFF Pharmaceuticals Inc develops and commercializes innovative inhalable therapeutics using its proprietary Thin Film Freezing technology. Its focus areas include respiratory diseases, infectious diseases, and immunology. The company is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TFFP
Country
🇺🇸 United States